Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-08-22

AUTHORS

Robin Goforth, Aliasger K. Salem, Xiaoyan Zhu, Suzanne Miles, Xue-Qing Zhang, John H. Lee, Anthony D. Sandler

ABSTRACT

Anti-tumor vaccines capable of activating both CD4 and CD8 T cells are preferred for long lasting T cell responses. Induction of a tumor-specific T-cell response can be induced by tumor vaccines that target innate immunity. The ensuing T-cell response depends on efficient antigen presentation from phagocytosed cargo in the antigen presenting cell and is augmented by the presence of Toll-like receptor (TLR) ligands within the cargo. Biodegradable polymers are useful for vaccine delivery in that they are phagocytosed by antigen presenting cells (APCs) and could potentially be loaded with both the antigen and immune stimulatory TLR agents. This study was undertaken to evaluate the effect of poly lactic-co-glycolic acid (PLGA) polymer particles loaded with antigenic tumor lysate and immune stimulatory CpG oligonucleotides on induction of tumor specific immunity in a mouse model of melanoma. We found that after delivery, these immune stimulatory antigen loaded particles (ISAPs) efficiently activated APCs and were incorporated into lysosomal compartments of macrophages and dendritic cells. ISAP vaccination resulted in remarkable T cell proliferation, but only modestly suppressed tumor growth of established melanoma. Due to this discordant effect on tumor immunity we evaluated the role of regulatory T cells (Treg) and found that ISAP vaccination or tumor growth alone induced prolific expansion of tumor specific Treg. When the Treg compartment was suppressed with anti-CD25 antibody, ISAP vaccination induced complete antigen-specific immunity in a prophylactic model. ISAP vaccination is a novel tumor vaccine strategy that is designed to co-load the antigen with a TLR agonist enabling efficient Ag presentation. Targeting of T-reg expansion during vaccination may be necessary for inducing effective tumor-specific immunity. More... »

PAGES

517-530

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00262-008-0574-6

DOI

http://dx.doi.org/10.1007/s00262-008-0574-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000429501

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18719913


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigen Presentation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigen-Presenting Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cancer Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligodeoxyribonucleotides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyglycolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polylactic Acid-Polyglycolic Acid Copolymer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Regulatory", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Toll-Like Receptors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214572.7", 
          "name": [
            "Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goforth", 
        "givenName": "Robin", 
        "id": "sg:person.01312415714.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312415714.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214572.7", 
          "name": [
            "Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salem", 
        "givenName": "Aliasger K.", 
        "id": "sg:person.01275627330.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275627330.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214572.7", 
          "name": [
            "Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Xiaoyan", 
        "id": "sg:person.0635125014.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635125014.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery and Center for Cancer Immunology, Children\u2019s National Medical Center, Washington DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.239560.b", 
          "name": [
            "Department of Surgery and Center for Cancer Immunology, Children\u2019s National Medical Center, Washington DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miles", 
        "givenName": "Suzanne", 
        "id": "sg:person.0737150132.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737150132.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214572.7", 
          "name": [
            "Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xue-Qing", 
        "id": "sg:person.0727031724.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727031724.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Otolaryngology, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214572.7", 
          "name": [
            "Department of Otolaryngology, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "John H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pediatric Surgery, Children\u2019s National Medical Center, 111 Michigan Avenue, 20010, Washington DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.239560.b", 
          "name": [
            "Department of Surgery and Center for Cancer Immunology, Children\u2019s National Medical Center, Washington DC, USA", 
            "Division of Pediatric Surgery, Children\u2019s National Medical Center, 111 Michigan Avenue, 20010, Washington DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sandler", 
        "givenName": "Anthony D.", 
        "id": "sg:person.0713174763.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713174763.89"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/32588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048341608", 
          "https://doi.org/10.1038/32588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04596", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003374226", 
          "https://doi.org/10.1038/nature04596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni1389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010084882", 
          "https://doi.org/10.1038/ni1389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bfb0043062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030214004", 
          "https://doi.org/10.1007/bfb0043062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004289511", 
          "https://doi.org/10.1038/nri1806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018394979", 
          "https://doi.org/10.1038/nrd2059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni1112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052724075", 
          "https://doi.org/10.1038/ni1112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/3-540-32636-7_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006572773", 
          "https://doi.org/10.1007/3-540-32636-7_2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35047123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001385025", 
          "https://doi.org/10.1038/35047123"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-08-22", 
    "datePublishedReg": "2008-08-22", 
    "description": "Anti-tumor vaccines capable of activating both CD4 and CD8 T cells are preferred for long lasting T cell responses. Induction of a tumor-specific T-cell response can be induced by tumor vaccines that target innate immunity. The ensuing T-cell response depends on efficient antigen presentation from phagocytosed cargo in the antigen presenting cell and is augmented by the presence of Toll-like receptor (TLR) ligands within the cargo. Biodegradable polymers are useful for vaccine delivery in that they are phagocytosed by antigen presenting cells (APCs) and could potentially be loaded with both the antigen and immune stimulatory TLR agents. This study was undertaken to evaluate the effect of poly lactic-co-glycolic acid (PLGA) polymer particles loaded with antigenic tumor lysate and immune stimulatory CpG oligonucleotides on induction of tumor specific immunity in a mouse model of melanoma. We found that after delivery, these immune stimulatory antigen loaded particles (ISAPs) efficiently activated APCs and were incorporated into lysosomal compartments of macrophages and dendritic cells. ISAP vaccination resulted in remarkable T cell proliferation, but only modestly suppressed tumor growth of established melanoma. Due to this discordant effect on tumor immunity we evaluated the role of regulatory T cells (Treg) and found that ISAP vaccination or tumor growth alone induced prolific expansion of tumor specific Treg. When the Treg compartment was suppressed with anti-CD25 antibody, ISAP vaccination induced complete antigen-specific immunity in a prophylactic model. ISAP vaccination is a novel tumor vaccine strategy that is designed to co-load the antigen with a TLR agonist enabling efficient Ag presentation. Targeting of T-reg expansion during vaccination may be necessary for inducing effective tumor-specific immunity.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00262-008-0574-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "58"
      }
    ], 
    "keywords": [
      "Toll-like receptors", 
      "tumor specific immunity", 
      "cell responses", 
      "specific immunity", 
      "stimulatory antigens", 
      "mouse model", 
      "effective tumor-specific immunity", 
      "tumor growth", 
      "tumor-specific immunity", 
      "antigen-specific immunity", 
      "anti-tumor vaccines", 
      "immune stimulatory CpG", 
      "tumor vaccine strategies", 
      "CD8 T cells", 
      "efficient antigen presentation", 
      "efficient Ag presentation", 
      "reg expansion", 
      "Treg compartment", 
      "CD25 antibody", 
      "specific Tregs", 
      "tumor vaccines", 
      "tumor immunity", 
      "prophylactic model", 
      "dendritic cells", 
      "vaccine strategies", 
      "TLR agonists", 
      "tumor lysate", 
      "stimulatory CpG", 
      "antigen presentation", 
      "T cells", 
      "Ag presentation", 
      "vaccination", 
      "innate immunity", 
      "discordant effects", 
      "vaccine delivery", 
      "antigen", 
      "immunity", 
      "melanoma", 
      "cell proliferation", 
      "vaccine", 
      "cells", 
      "presentation", 
      "induction", 
      "response", 
      "Tregs", 
      "lysosomal compartment", 
      "CD4", 
      "delivery", 
      "agonists", 
      "macrophages", 
      "receptors", 
      "antibodies", 
      "compartments", 
      "APC", 
      "proliferation", 
      "prolific expansion", 
      "effect", 
      "agents", 
      "CpG", 
      "depletion", 
      "lysates", 
      "study", 
      "role", 
      "presence", 
      "growth", 
      "strategies", 
      "model", 
      "expansion", 
      "acid polymers", 
      "cargo", 
      "biodegradable polymers", 
      "particles", 
      "polymers", 
      "immune stimulatory TLR agents", 
      "stimulatory TLR agents", 
      "TLR agents", 
      "poly lactic-co-glycolic acid (PLGA) polymer", 
      "lactic-co-glycolic acid (PLGA) polymer", 
      "antigenic tumor lysate", 
      "immune stimulatory antigen", 
      "ISAP vaccination", 
      "tumor specific Treg", 
      "complete antigen-specific immunity", 
      "novel tumor vaccine strategy", 
      "potent tumor specific immunity"
    ], 
    "name": "Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma", 
    "pagination": "517-530", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000429501"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00262-008-0574-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18719913"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00262-008-0574-6", 
      "https://app.dimensions.ai/details/publication/pub.1000429501"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_463.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00262-008-0574-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00262-008-0574-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00262-008-0574-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00262-008-0574-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00262-008-0574-6'


 

This table displays all metadata directly associated to this object as RDF triples.

309 TRIPLES      22 PREDICATES      139 URIs      122 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00262-008-0574-6 schema:about N0bf9017477b84d1f97d8ff9a8e188f35
2 N168e9ee832ed4e308791836083549813
3 N18d79135cec2457283dd2793367c579a
4 N27a4b655ebe8446a8d5ae0ec5accb392
5 N4a208882aa1c45ee80fea5c717ba0e04
6 N6a4c8aa41acb495ab40d93bc520f358e
7 N6c68b3e7d4d0425e8defce0d664284d1
8 N8a661abc306a4827829446c2afcf9e6c
9 N8f8643c6fb724bc1adcaadf519cb3e1c
10 N9b346fbeb60e40d3bd9079b59ec685ec
11 Nb49c1fef02fb4f66b1bd4ca1dd15cff6
12 Nb79eb94bd0454faa9a5d4943b1dc7788
13 Nb85fc69dd9cb415ba113dd24eb01468a
14 Nba4e6cec2585491da982e98fb0709a21
15 Nc9ee96fc79a34c7c935f7c284ddfbcea
16 Ndb7d2350a31748bd80ba421d84b86574
17 Ne0e42412f2204990845e89d20f7585d6
18 Ne3b620be912444dd87df504a373e0617
19 Nf776672e5d70415788be1b918a0d9751
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author Nd3b5008569bd4dff905e8d7f4b7523c6
23 schema:citation sg:pub.10.1007/3-540-32636-7_2
24 sg:pub.10.1007/bfb0043062
25 sg:pub.10.1038/32588
26 sg:pub.10.1038/35047123
27 sg:pub.10.1038/nature04596
28 sg:pub.10.1038/ni1112
29 sg:pub.10.1038/ni1389
30 sg:pub.10.1038/nrd2059
31 sg:pub.10.1038/nri1806
32 schema:datePublished 2008-08-22
33 schema:datePublishedReg 2008-08-22
34 schema:description Anti-tumor vaccines capable of activating both CD4 and CD8 T cells are preferred for long lasting T cell responses. Induction of a tumor-specific T-cell response can be induced by tumor vaccines that target innate immunity. The ensuing T-cell response depends on efficient antigen presentation from phagocytosed cargo in the antigen presenting cell and is augmented by the presence of Toll-like receptor (TLR) ligands within the cargo. Biodegradable polymers are useful for vaccine delivery in that they are phagocytosed by antigen presenting cells (APCs) and could potentially be loaded with both the antigen and immune stimulatory TLR agents. This study was undertaken to evaluate the effect of poly lactic-co-glycolic acid (PLGA) polymer particles loaded with antigenic tumor lysate and immune stimulatory CpG oligonucleotides on induction of tumor specific immunity in a mouse model of melanoma. We found that after delivery, these immune stimulatory antigen loaded particles (ISAPs) efficiently activated APCs and were incorporated into lysosomal compartments of macrophages and dendritic cells. ISAP vaccination resulted in remarkable T cell proliferation, but only modestly suppressed tumor growth of established melanoma. Due to this discordant effect on tumor immunity we evaluated the role of regulatory T cells (Treg) and found that ISAP vaccination or tumor growth alone induced prolific expansion of tumor specific Treg. When the Treg compartment was suppressed with anti-CD25 antibody, ISAP vaccination induced complete antigen-specific immunity in a prophylactic model. ISAP vaccination is a novel tumor vaccine strategy that is designed to co-load the antigen with a TLR agonist enabling efficient Ag presentation. Targeting of T-reg expansion during vaccination may be necessary for inducing effective tumor-specific immunity.
35 schema:genre article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf N136c2ab6f3c64ab2b7cae0490a3b6c50
39 N8207a2451f194a09996aa180d2278519
40 sg:journal.1096240
41 schema:keywords APC
42 Ag presentation
43 CD25 antibody
44 CD4
45 CD8 T cells
46 CpG
47 ISAP vaccination
48 T cells
49 TLR agents
50 TLR agonists
51 Toll-like receptors
52 Treg compartment
53 Tregs
54 acid polymers
55 agents
56 agonists
57 anti-tumor vaccines
58 antibodies
59 antigen
60 antigen presentation
61 antigen-specific immunity
62 antigenic tumor lysate
63 biodegradable polymers
64 cargo
65 cell proliferation
66 cell responses
67 cells
68 compartments
69 complete antigen-specific immunity
70 delivery
71 dendritic cells
72 depletion
73 discordant effects
74 effect
75 effective tumor-specific immunity
76 efficient Ag presentation
77 efficient antigen presentation
78 expansion
79 growth
80 immune stimulatory CpG
81 immune stimulatory TLR agents
82 immune stimulatory antigen
83 immunity
84 induction
85 innate immunity
86 lactic-co-glycolic acid (PLGA) polymer
87 lysates
88 lysosomal compartment
89 macrophages
90 melanoma
91 model
92 mouse model
93 novel tumor vaccine strategy
94 particles
95 poly lactic-co-glycolic acid (PLGA) polymer
96 polymers
97 potent tumor specific immunity
98 presence
99 presentation
100 proliferation
101 prolific expansion
102 prophylactic model
103 receptors
104 reg expansion
105 response
106 role
107 specific Tregs
108 specific immunity
109 stimulatory CpG
110 stimulatory TLR agents
111 stimulatory antigens
112 strategies
113 study
114 tumor growth
115 tumor immunity
116 tumor lysate
117 tumor specific Treg
118 tumor specific immunity
119 tumor vaccine strategies
120 tumor vaccines
121 tumor-specific immunity
122 vaccination
123 vaccine
124 vaccine delivery
125 vaccine strategies
126 schema:name Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma
127 schema:pagination 517-530
128 schema:productId N92a981d6b6384d1c896187532a95001d
129 Nd4b7a52764e8478399f0b60bff522a64
130 Nfc5028072fc045d885b5217320e7035b
131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000429501
132 https://doi.org/10.1007/s00262-008-0574-6
133 schema:sdDatePublished 2021-12-01T19:21
134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
135 schema:sdPublisher N2f4984cf15894a039922008c441d4141
136 schema:url https://doi.org/10.1007/s00262-008-0574-6
137 sgo:license sg:explorer/license/
138 sgo:sdDataset articles
139 rdf:type schema:ScholarlyArticle
140 N02f9edcecf7f418fa09503a4439164cf rdf:first sg:person.0635125014.55
141 rdf:rest N9752da6fb1254185b33b0fec784a3580
142 N0bf9017477b84d1f97d8ff9a8e188f35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Antigen Presentation
144 rdf:type schema:DefinedTerm
145 N136c2ab6f3c64ab2b7cae0490a3b6c50 schema:issueNumber 4
146 rdf:type schema:PublicationIssue
147 N168e9ee832ed4e308791836083549813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name T-Lymphocytes, Regulatory
149 rdf:type schema:DefinedTerm
150 N18d79135cec2457283dd2793367c579a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Polyglycolic Acid
152 rdf:type schema:DefinedTerm
153 N205d47ce902f4c29912b8612909d0ad6 rdf:first N40f5c2ae8cab41f4a8f5665a3dc16252
154 rdf:rest Nf0098a5e32344c42b402beccd95d5fd5
155 N225c9ab0c965496c944a28bafbc58a46 rdf:first sg:person.0727031724.15
156 rdf:rest N205d47ce902f4c29912b8612909d0ad6
157 N27a4b655ebe8446a8d5ae0ec5accb392 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Toll-Like Receptors
159 rdf:type schema:DefinedTerm
160 N2f4984cf15894a039922008c441d4141 schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N40f5c2ae8cab41f4a8f5665a3dc16252 schema:affiliation grid-institutes:grid.214572.7
163 schema:familyName Lee
164 schema:givenName John H.
165 rdf:type schema:Person
166 N4a208882aa1c45ee80fea5c717ba0e04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Immunotherapy
168 rdf:type schema:DefinedTerm
169 N6a4c8aa41acb495ab40d93bc520f358e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Lymphocyte Activation
171 rdf:type schema:DefinedTerm
172 N6c68b3e7d4d0425e8defce0d664284d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Oligodeoxyribonucleotides
174 rdf:type schema:DefinedTerm
175 N8207a2451f194a09996aa180d2278519 schema:volumeNumber 58
176 rdf:type schema:PublicationVolume
177 N8a661abc306a4827829446c2afcf9e6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Melanoma, Experimental
179 rdf:type schema:DefinedTerm
180 N8f8643c6fb724bc1adcaadf519cb3e1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Cancer Vaccines
182 rdf:type schema:DefinedTerm
183 N92a981d6b6384d1c896187532a95001d schema:name pubmed_id
184 schema:value 18719913
185 rdf:type schema:PropertyValue
186 N9752da6fb1254185b33b0fec784a3580 rdf:first sg:person.0737150132.05
187 rdf:rest N225c9ab0c965496c944a28bafbc58a46
188 N9b346fbeb60e40d3bd9079b59ec685ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Mice
190 rdf:type schema:DefinedTerm
191 Nb49c1fef02fb4f66b1bd4ca1dd15cff6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Mice, Inbred C57BL
193 rdf:type schema:DefinedTerm
194 Nb79eb94bd0454faa9a5d4943b1dc7788 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Lactic Acid
196 rdf:type schema:DefinedTerm
197 Nb85fc69dd9cb415ba113dd24eb01468a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Flow Cytometry
199 rdf:type schema:DefinedTerm
200 Nba4e6cec2585491da982e98fb0709a21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Enzyme-Linked Immunosorbent Assay
202 rdf:type schema:DefinedTerm
203 Nc9ee96fc79a34c7c935f7c284ddfbcea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Female
205 rdf:type schema:DefinedTerm
206 Nd3b5008569bd4dff905e8d7f4b7523c6 rdf:first sg:person.01312415714.96
207 rdf:rest Ndd0de29b4e7a432899a8e917f02a4bd9
208 Nd4b7a52764e8478399f0b60bff522a64 schema:name dimensions_id
209 schema:value pub.1000429501
210 rdf:type schema:PropertyValue
211 Ndb7d2350a31748bd80ba421d84b86574 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Polylactic Acid-Polyglycolic Acid Copolymer
213 rdf:type schema:DefinedTerm
214 Ndd0de29b4e7a432899a8e917f02a4bd9 rdf:first sg:person.01275627330.47
215 rdf:rest N02f9edcecf7f418fa09503a4439164cf
216 Ne0e42412f2204990845e89d20f7585d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Antigens, Neoplasm
218 rdf:type schema:DefinedTerm
219 Ne3b620be912444dd87df504a373e0617 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Antigen-Presenting Cells
221 rdf:type schema:DefinedTerm
222 Nf0098a5e32344c42b402beccd95d5fd5 rdf:first sg:person.0713174763.89
223 rdf:rest rdf:nil
224 Nf776672e5d70415788be1b918a0d9751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Animals
226 rdf:type schema:DefinedTerm
227 Nfc5028072fc045d885b5217320e7035b schema:name doi
228 schema:value 10.1007/s00262-008-0574-6
229 rdf:type schema:PropertyValue
230 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
231 schema:name Medical and Health Sciences
232 rdf:type schema:DefinedTerm
233 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
234 schema:name Immunology
235 rdf:type schema:DefinedTerm
236 sg:journal.1096240 schema:issn 0340-7004
237 1432-0851
238 schema:name Cancer Immunology, Immunotherapy
239 schema:publisher Springer Nature
240 rdf:type schema:Periodical
241 sg:person.01275627330.47 schema:affiliation grid-institutes:grid.214572.7
242 schema:familyName Salem
243 schema:givenName Aliasger K.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275627330.47
245 rdf:type schema:Person
246 sg:person.01312415714.96 schema:affiliation grid-institutes:grid.214572.7
247 schema:familyName Goforth
248 schema:givenName Robin
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312415714.96
250 rdf:type schema:Person
251 sg:person.0635125014.55 schema:affiliation grid-institutes:grid.214572.7
252 schema:familyName Zhu
253 schema:givenName Xiaoyan
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635125014.55
255 rdf:type schema:Person
256 sg:person.0713174763.89 schema:affiliation grid-institutes:grid.239560.b
257 schema:familyName Sandler
258 schema:givenName Anthony D.
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713174763.89
260 rdf:type schema:Person
261 sg:person.0727031724.15 schema:affiliation grid-institutes:grid.214572.7
262 schema:familyName Zhang
263 schema:givenName Xue-Qing
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727031724.15
265 rdf:type schema:Person
266 sg:person.0737150132.05 schema:affiliation grid-institutes:grid.239560.b
267 schema:familyName Miles
268 schema:givenName Suzanne
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737150132.05
270 rdf:type schema:Person
271 sg:pub.10.1007/3-540-32636-7_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006572773
272 https://doi.org/10.1007/3-540-32636-7_2
273 rdf:type schema:CreativeWork
274 sg:pub.10.1007/bfb0043062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030214004
275 https://doi.org/10.1007/bfb0043062
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/32588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048341608
278 https://doi.org/10.1038/32588
279 rdf:type schema:CreativeWork
280 sg:pub.10.1038/35047123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001385025
281 https://doi.org/10.1038/35047123
282 rdf:type schema:CreativeWork
283 sg:pub.10.1038/nature04596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003374226
284 https://doi.org/10.1038/nature04596
285 rdf:type schema:CreativeWork
286 sg:pub.10.1038/ni1112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052724075
287 https://doi.org/10.1038/ni1112
288 rdf:type schema:CreativeWork
289 sg:pub.10.1038/ni1389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010084882
290 https://doi.org/10.1038/ni1389
291 rdf:type schema:CreativeWork
292 sg:pub.10.1038/nrd2059 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018394979
293 https://doi.org/10.1038/nrd2059
294 rdf:type schema:CreativeWork
295 sg:pub.10.1038/nri1806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004289511
296 https://doi.org/10.1038/nri1806
297 rdf:type schema:CreativeWork
298 grid-institutes:grid.214572.7 schema:alternateName Department of Otolaryngology, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA
299 Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA
300 Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA
301 schema:name Department of Otolaryngology, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA
302 Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, Iowa, IA, USA
303 Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa, IA, USA
304 rdf:type schema:Organization
305 grid-institutes:grid.239560.b schema:alternateName Department of Surgery and Center for Cancer Immunology, Children’s National Medical Center, Washington DC, USA
306 Division of Pediatric Surgery, Children’s National Medical Center, 111 Michigan Avenue, 20010, Washington DC, USA
307 schema:name Department of Surgery and Center for Cancer Immunology, Children’s National Medical Center, Washington DC, USA
308 Division of Pediatric Surgery, Children’s National Medical Center, 111 Michigan Avenue, 20010, Washington DC, USA
309 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...